Top Tweets for #PfizerKnew

Naomi Wolf reveals a bombshell: Pfizer knew of 1,225 deaths within just three months of vaccine rollout. They also knew by April 2021 that the shot was damaging minors' hearts, per warnings from Israel and pediatric experts. Instead of warning the public, internal emails show a full freak-out at the highest levels. The chain reached 15 White House officials and even a template for POTUS. Their response? A 17-page redacted script on how to lie to the American people. The plan: downplay it as "mild, transient, and rare" myocarditis. Then, they launched a summer-long propaganda campaign using influencers and TikTok stars to push the shot on teens. They knew. They lied. And they marketed it to your children.

They Knew. They All Knew. They Terminated Everyone Who Stood Against Them. “I was fired after 31 years as an emergency room physician with not one single patient complaint against me in those 31 years.” “I was fired for saying that somebody who had natural immunity didn't need to be vaccinated against the disease to which they were already immune. Fortunately, I still had my medical license even though I lost a significant part at least 50% of my income and I couldn't work as an emergency room doctor anymore. I still had my private practice. So when I discovered from the biodistribution studies that Pfizer had hidden, that we knew that these vaccines go around your entire body. They do not just stay in your arm. Pfizer's bio distribution studies on the lipid nanoparticles show that they literally take those messenger RNA strands into every part of your body. They go into your brain and your lungs and your heart and your liver and your reproductive organs and your bone marrow and everywhere, which is, by the way, why these COVID shots have caused a a greater array of side effects than any other medical treatment in history. Because this toxic spike protein ends up in literally every part of your body.”

🚩 New Zealand Study Finds a Statistically Significant Increase in Myo/Pericarditis and Single Organ Cutaneous Vasculitis in Children & Young Adults Post-Pfizer Vaccination “The highest SIR was 25.6 (15.5-37.5) in the 5-19 years age group, following the second dose of the vaccine, with an estimated five additional myo/pericarditis cases per 100,000 persons vaccinated. A statistically significant increased SIR of single organ cutaneous vasculitis (SOCV) was also observed following the first dose of BNT162b2 in the 20-39 years age group only.”

FDA Science: Childhood Vaccine Clinical Trial Series (Part 17 of 17) The Dengue vaccine is the 17th and last vaccine on the CDC’s childhood vaccine schedule, and the first vaccine that apparently underwent a longer-term placebo-controlled trial prior to licensure! This trial stands as the proof that a longer-term placebo-controlled trial of a childhood vaccine is possible! --Dengvaxia (Sanofi) licensed based on a trial with 11,474 children receiving a placebo control (saline injection) & 5 years of safety review after injection. For this vaccine, it was learned that children under 6 years old had an increased risk of severe harm and death from this vaccine – harm that would likely never be uncovered by the trials performed for any of the other 16 vaccines in this series. It was also found that children older than 6 who had never had dengue and received this vaccine likewise had a seriously increased risk of severe harm and death. Hence, this vaccine is only to be given to older children who have previously had dengue. As disclosed by the FDA and Sanofi: “Those not previously infected are at increased risk for severe dengue disease when vaccinated and subsequently infected with dengue virus.” This vaccine is only recommended for children in endemic dengue areas and dengue is not endemic in the United States. Source: https://t.co/frPPrqvwc4(See page 10 of the FDA Statistical Review for Dengvaxia summarizing the clinical trials for this vaccine and see page 1 for disclaimer regarding harm it can cause in children not previously infected with dengue); https://t.co/qzxCHrvRMy(See Warnings and Precautions stating “DENGVAXIA is not approved for use in individuals younger than 6 years of age. In persons younger than 6 years of age regardless of previous infection by dengue virus, an increased risk of severe and hospitalized dengue disease can occur following vaccination”); https://t.co/ahuLts6Vlm; https://t.co/n38mt0X8dd (CDC childhood vaccine schedule providing Dengvaxia is only for children “Seropositive [meaning they previously had dengue] in endemic dengue areas”).

FDA Science: Childhood Vaccine Clinical Trial Series (Part 16 of 17) “The clinical trials for PPSV23 (pneumococcal polysaccharide) vaccine, injected starting at 2 years to certain populations, showed it was safe to license!” It’s misinformation to claim otherwise! --Pneumovax 23 (Merck) is licensed for children 2 years and older but there is no indication that there was any clinical trial involving anyone younger than 16 years of age that the FDA relied upon to license this vaccine. The package insert and FDA documentation regarding licensure of this product is included in the link below. Source: https://t.co/Y9bcZ6VeL1(FDA documentation regarding licensure of Pneumovax 23); https://t.co/n38mt0X8dd (CDC childhood vaccine schedule).

FDA Science: Childhood Vaccine Clinical Trial Series (Part 15 of 17) “The clinical trials for MenB (meningococcal serogroup B) vaccines, injected starting at 10 years of age to certain populations, showed they were safe to license!” It’s misinformation to claim otherwise! --Bexsero (GSK) licensed based on trials with no placebo control group (either uncontrolled or control group was given an injection of aluminum hydroxide and, in one trial involving 120 adolescents, a saline injection followed by an injection of Menveo and hence FDA labels this an “active control” and not a “placebo control” trial) & 30 days of safety review after injection. --Trumenba (Pfizer) licensed based on trials with no placebo control group other than 12 people in a dose ranging phase II study (otherwise the controls were injection of Gardasil+placebo, dTaP-IPV+placebo, HepA+placebo, or Menactra+Adacel+placebo) & 30 days of safety review after injection for one of the three trials and up to 11 months in the other two trials. Source: https://t.co/Iwy8opqmdn(See pages 14 and 15 of FDA Summary Basis of Regulatory Action for Bexsero outlining the clinical trials); https://t.co/qlOvNpVmZc(See page 40 of the FDA Clinical Review for Bexsero admitting the purported “Placebo” included aluminum hydroxide); https://t.co/scTT4fCMyU(See page 4 of FDA Summary Basis of Regulatory action for Trumenba describing the trials completed after accelerated approval); https://t.co/lc2iv440A3(See pages 9 and 10 of the FDA Clinical Review for Trumenba describing the initial trials relied upon for licensure); https://t.co/n38mt0X8dd (CDC childhood vaccine schedule).